Cite
APA Citation
Poosti, F., Soebadi, M. A., Crijns, H., De Zutter, A., Metzemaekers, M., Berghmans, N., Vanheule, V., Albersen, M., Opdenakker, G., Van Damme, J., Sprangers, B., Proost, P., & Struyf, S. (2022). inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide. Clinical & translational immunology, 11(2), n/a. http://access.bl.uk/ark:/81055/vdc_100152321732.0x000011